PITYRIASIS RUBRA PILARIS

Clinical trials for PITYRIASIS RUBRA PILARIS explained in plain language.

Never miss a new study

Get alerted when new PITYRIASIS RUBRA PILARIS trials appear

Sign up with your email to follow new studies for PITYRIASIS RUBRA PILARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for stubborn skin disease in small trial

Disease control Recruiting now

This study is testing if an oral medication called Deucravacitinib is safe and effective for treating Pityriasis Rubra Pilaris (PRP), a rare and often severe inflammatory skin disease. It will enroll 12 adults with moderate-to-severe PRP to see if the drug improves their skin con…

Matched conditions: PITYRIASIS RUBRA PILARIS

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

PITYRIASIS RUBRA PILARIS

Get alerted when new PITYRIASIS RUBRA PILARIS trials appear

New hope for stubborn skin disease in small trial